Epstein Secrets

e AP (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average - in a large study led by the U.S. National Institutes of Health." The drug

ember 21st at the federal court in Central Islip would see both federal prosecutors and defense attorneys question Singh before U.S. District Judge Joan Azrack. The motion to overturn the Manganos' convictions and grant them a new trial is one of a number filed by the couple's defense attorneys to overturn

63> (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average — in a large study led by the U.S. National Institutes of Health." The drug

ember 21st at the federal court in Central Islip would see both federal prosecutors and defense attorneys question Singh before U.S. District Judge Joan Azrack. The motion to overturn the Manganos' convictions and grant them a new trial is one of a number filed by the couple's defense attorneys to overturn

e AP (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average - in a large study led by the U.S. National Institutes of Health." The drug

cember 21st at the federal court in Central Islip would see both federal prosecutors and defense attorneys question Singh before U.S. District Judge Joan Azrack. The motion to overturn the Manganos' convictions and grant them a new trial is one of a number filed by the couple's defense attorneys to overturn